Premetrexed combined with paclitaxel in NSCLC phase I-II

被引：0
|
作者：
Stathopoulos, George P. [1 ]
Dimitroulis, John [1 ]
Toubis, Michael [1 ]
Katis, Costas [1 ]
Karaindros, Dimitris [1 ]
Stathopoulos, John [1 ]
Koutandos, John [1 ]
机构：
[1] Errikos Dunant Hosp, Solca Grp, Oncol Clin A, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [21] Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer
    Shirao, K
    Shimada, Y
    Kondo, H
    Saito, D
    Yamao, T
    Ono, H
    Yokoyama, T
    Fukuda, H
    Oka, M
    Watanabe, Y
    Ohtsu, A
    Boku, N
    Fujii, T
    Oda, Y
    Muro, K
    Yoshida, S
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 921 - 927
  • [22] Phase I-II study of escalating doses of amifostine combined with high-dose cyclophosphamide
    Michele Ghielmini
    Sabine Van der Bosch
    Manuela Bosshard
    Sandro Pampallona
    Luca Gabutti
    Hans-Peter Egger
    Markus Kiess
    Franco Cavalli
    Cristiana Sessa
    Cancer Chemotherapy and Pharmacology, 2001, 47 : 532 - 536
  • [23] Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: Phase I-II study
    Gilly, FN
    Beaujard, A
    Glehen, O
    Grandclement, E
    Caillot, JL
    Francois, Y
    Sadeghi-Looyeh, B
    Gueugniaud, PY
    Garbit, F
    Benoit, M
    Bienvenu, J
    Vignal, J
    ANTICANCER RESEARCH, 1999, 19 (3B) : 2317 - 2321
  • [24] Phase I-II study of escalating doses of amifostine combined with high-dose cyclophosphamide
    Ghielmini, M
    Van der Bosch, S
    Bosshard, M
    Pampallona, S
    Gabutti, L
    Egger, HP
    Kiess, M
    Cavalli, F
    Sessa, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 47 (06) : 532 - 536
  • [25] Escalating doses of paclitaxel and epirubicin in combination with cisplatin in advanced ovarian epithelial carcinoma: a phase I-II study
    Gebbia, V
    Di Marco, P
    Borsellino, N
    Gebbia, N
    Valerio, MR
    Fallica, G
    Tirrito, ML
    Valenza, R
    Citarrella, P
    Panici, PB
    ANTI-CANCER DRUGS, 2003, 14 (05) : 359 - 364
  • [26] PHASE I-II EVALUATION OF PIPERAZINEDIONE IN CHILDREN WITH CANCER
    PRATT, C
    RIVERA, G
    SHANKS, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 82 - 82
  • [27] RADIOFREQUENCY HYPERTHERMIA IN MALIGNANCY - A PHASE I-II STUDY
    KHANDEKAR, JD
    SCANLON, EF
    GARCES, RM
    LAWRENCE, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 158 - 158
  • [28] ORAL DIANHYDROGALACTITOL (DAG) - PHASE I-II STUDY
    DEJAGER, R
    BRUGAROLAS, A
    HANSEN, H
    CAVALLI, F
    WENNERHOLM, A
    KENIS, Y
    ALBERTO, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 295 - 295
  • [29] Phase I-II studies in clinical radiation oncology
    Ricardi, U
    TUMORI, 2001, 87 (04) : S45 - S46
  • [30] PHASE I-II STUDIES OF ORAL TEGAFUR (FTORAFUR)
    ANSFIELD, FJ
    KALLAS, GJ
    SINGSON, JP
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (02) : 107 - 110
12345